Archive for August, 2008

Cell Genesys, Inc. (CEGE) Halts Cancer Treatment Trial to Ensure …

We are currently notifying all participating clinical trial sites and regulatory agencies that enrollment of new patients into VITAL-2 has been suspended as has treatment with GVAX immunotherapy for prostate cancer of patients enrolled …

CancerDirectory.com » Blog Archive » Review: Cancer Treatment …

At CTCA, patients will receive a personalized treatment plan including a powerful combination of advanced conventional treatments combined with supportive complementary medicine therapies. This whole-person approach helps fight cancer …

Review: Cancer Treatment Centers of America (CTCA …

At CTCA, patients will receive a personalized treatment plan including a powerful combination of advanced conventional treatments combined with supportive complementary medicine therapies. This whole-person approach helps fight cancer …